Stoichiometry of N-methyl-D-aspartate receptors within the suprachiasmatic nucleus

Journal of Neurophysiology

Volumn 103, Issue 6, 2010, Pages 3448-3464

  Clark III, J P ^a   Kofuji, P ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IFENPRODIL; MAGNESIUM; N METHYL DEXTRO ASPARTIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN SLICE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOICHIOMETRY; SUPRACHIASMATIC NUCLEUS; VOLTAGE CLAMP; WHOLE CELL;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; MAGNESIUM; MICE; MICE, INBRED C57BL; NEURONS; PATCH-CLAMP TECHNIQUES; PHENOLS; PIPERIDINES; PROTEIN SUBUNITS; RECEPTORS, N-METHYL-D-ASPARTATE; SUPRACHIASMATIC NUCLEUS;

EID: 77953503373     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.01069.2009     Document Type: Article

References (80)

1. Al-Hallaq RA, Jarabek BR, Fu Z, Vicini S, Wolfe BB, Yasuda RP. Association of NR3A with the N-methyl-D-aspartate receptor NR1 and NR2 subunits. Mol Pharmacol 62: 1119-1127, 2002.
2. Ali DW, Salter MW. NMDA receptor regulation by Src kinase signalling in excitatory synaptic transmission and plasticity. Curr Opin Neurobiol 11: 336-342, 2001.
3. Bendova Z, Sumova A, Mikkelsen JD. Circadian and developmental regulation of N-methyl-D-aspartate-receptor 1 mRNA splice variants and N-methyl-D-aspartate-receptor 3 subunit expression within the rat suprachiasmatic nucleus. Neuroscience 159: 599-609, 2009.
4. Berson DM, Dunn FA, Takao M. Phototransduction by retinal ganglion cells that set the circadian clock. Science 295: 1070-1073, 2002.
5. Chatterton JE, Awobuluyi M, Premkumar LS, Takahashi H, Talantova M, Shin Y, Cui J, Tu S, Sevarino KA, Nakanishi N, Tong G, Lipton SA, Zhang D. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature 415: 793-798, 2002.
6. Choi YB, Lipton SA. Identification and mechanism of action of two histidine residues underlying high-affinity Zn2+ inhibition of the NMDA receptor. Neuron 23: 171-180, 1999.
7. Ciabarra AM, Sullivan JM, Gahn LG, Pecht G, Heinemann S, Sevarino KA. Cloning and characterization of chi-1: a developmentally regulated member of a novel class of the ionotropic glutamate receptor family. J Neurosci 15: 6498-6508, 1995. (Pubitemid 3001297)
8. Clark JP, 3rd, Sampair CS, Kofuji P, Nath A, Ding JM. HIV protein, transactivator of transcription, alters circadian rhythms through the light entrainment pathway. Am J Physiol Regul Integr Comp Physiol 289: R656-662, 2005.
9. Colwell CS. NMDA-evoked calcium transients and currents in the suprachiasmatic nucleus: gating by the circadian system. Eur J Neurosci 13: 1420-1428, 2001.
10. Colwell CS, Menaker M. NMDA as well as non-NMDA receptor antagonists can prevent the phase-shifting effects of light on the circadian system of the golden hamster. J Biol Rhythms 7: 125-136, 1992.
11. Cull-Candy SG, Leszkiewicz DN. Role of distinct NMDA receptor subtypes at central synapses. Sci STKE 2004: re16. 2004.
12. Das S, Sasaki YF, Rothe T, Premkumar LS, Takasu M, Crandall JE, Dikkes P, Conner DA, Rayudu PV, Cheung W, Chen HS, Lipton SA, Nakanishi N. Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature 393: 377-381, 1998.
13. Ding JM, Chen D, Weber ET, Faiman LE, Rea MA, Gillette MU. Resetting the biological clock: mediation of nocturnal circadian shifts by glutamate and NO. Science 266: 1713-1717, 1994.
14. Ding JM, Faiman LE, Hurst WJ, Kuriashkina LR, Gillette MU. Resetting the biological clock: mediation of nocturnal CREB phosphorylation via light, glutamate, and nitric oxide. J Neurosci 17: 667-675, 1997.
15. Ebling FJ. The role of glutamate in the photic regulation of the suprachiasmatic nucleus. Prog Neurobiol 50: 109-132, 1996.
16. Erreger K, Geballe MT, Kristensen A, Chen PE, Hansen KB, Lee CJ, Yuan H, Le P, Lyuboslavsky PN, Micale N, Jorgensen L, Clausen RP, Wyllie DJ, Snyder JP, Traynelis SF. Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors. Mol Pharmacol 72: 907-920, 2007.
17. Fischer G, Mutel V, Trube G, Malherbe P, Kew JN, Mohacsi E, Heitz MP, Kemp JA. Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro. J Pharmacol Exp Ther 283: 1285-1292, 1997. (Pubitemid 28016504)
18. Gannon RL, Rea MA. In situ hybridization of antisense mRNA oligonucleotides for AMPA, NMDA and metabotropic glutamate receptor subtypes in the rat suprachiasmatic nucleus at different phases of the circadian cycle. Brain Res Mol Brain Res 23: 338-344, 1994.
19. Gillette MU. The suprachiasmatic nuclei: circadian phase-shifts induced at the time of hypothalamic slice preparation are preserved in vitro. Brain Res 379: 176-181, 1986.
20. Gillette MU. Suprachiasmatic nucleus electrophysiology in vitro: rhythmic activity and endogenous clock properties. In: The Mind's Clock, edited by Klein DC, Moore R, Reppert S. New York: Oxford Univ. Press, 1991, p. 125-143.
21. Ginty DD, Kornhauser JM, Thompson MA, Bading H, Mayo KE, Takahashi JS, Greenberg ME. Regulation of CREB phosphorylation in the suprachiasmatic nucleus by light and a circadian clock. Science 260: 238-241, 1993. (Pubitemid 23140894)
22. Hannibal J. Neurotransmitters of the retino-hypothalamic tract. Cell Tissue Res 309: 73-88, 2002.
23. Harrington ME, Hoque S, Hall A, Golombek D, Biello S. Pituitary adenylate cyclase activating peptide phase shifts circadian rhythms in a manner similar to light. J Neurosci 19: 6637-6642, 1999. (Pubitemid 29347463)
24. Hattar S, Liao HW, Takao M, Berson DM, Yau KW. Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity. Science 295: 1065-1070, 2002.
25. Hatton CJ, Paoletti P. Modulation of triheteromeric NMDA receptors by N-terminal domain ligands. Neuron 46: 261-274, 2005.
26. Herzog ED. Neurons and networks in daily rhythms. Nat Rev Neurosci 8: 790-802, 2007.
27. 2+ mobilization mediated by GABAA and NMDA receptors in the suprachiasmatic nucleus. Eur J Neurosci 17: 58-70, 2003.
28. Ishida N, Matsui M, Mitsui Y, Mishina M. Circadian expression of NMDA receptor mRNAs, epsilon 3 and zeta 1, in the suprachiasmatic nucleus of rat brain. Neurosci Lett 166: 211-215, 1994.
29. Ishii T, Moriyoshi K, Sugihara H, Sakurada K, Kadotani H, Yokoi M, Akazawa C, Shigemoto R, Mizuno N, Masu M, Nakanishi S. Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J Biol Chem 268: 2836-2843, 1993. (Pubitemid 23057917)
30. Johnson RF, Moore RY, Morin LP. Loss of entrainment and anatomical plasticity after lesions of the hamster retinohypothalamic tract. Brain Res 460: 297-313, 1988.
31. Kew JN, Trube G, Kemp JA. A novel mechanism of activity-dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurones. J Physiol 497: 761-772, 1996. (Pubitemid 27032913)
32. Kim YI, Choi HJ, Colwell CS. Brain-derived neurotrophic factor regulation of N-methyl-D-aspartate receptor-mediated synaptic currents in suprachiasmatic nucleus neurons. J Neurosci Res 84: 1512-1520, 2006.
33. Kirson ED, Schirra C, Konnerth A, Yaari Y. Early postnatal switch in magnesium sensitivity of NMDA receptors in rat CA1 pyramidal cells. J Physiol 521: 99-111, 1999.
34. Kopp MD, Meissl H, Dehghani F, Korf HW. The pituitary adenylate cyclase-activating polypeptide modulates glutamatergic calcium signalling: investigations on rat suprachiasmatic nucleus neurons. J Neurochem 79: 161-171, 2001.
35. Kornhauser JM, Nelson DE, Mayo KE, Takahashi JS. Photic and circadian regulation of c-fos gene expression in the hamster suprachiasmatic nucleus. Neuron 5: 127-134, 1990.
36. Kornhauser JM, Nelson DE, Mayo KE, Takahashi JS. Regulation of jun-B messenger RNA and AP-1 activity by light and a circadian clock. Science 255: 1581-1584, 1992.
37. Kuner T, Schoepfer R. Multiple structural elements determine subunit specificity of Mg2+ block in NMDA receptor channels. J Neurosci 16: 3549-3558, 1996. (Pubitemid 26149494)
38. Kutsuwada T, Kashiwabuchi N, Mori H, Sakimura K, Kushiya E, Araki K, Meguro H, Masaki H, Kumanishi T, Arakawa M, Mishina M. Molecular diversity of the NMDA receptor channel. Nature 358: 36-41, 1992.
39. Low CM, Zheng F, Lyuboslavsky P, Traynelis SF. Molecular determinants of coordinated proton and zinc inhibition of N-methyl-D-aspartate NR1/NR2A receptors. Proc Natl Acad Sci USA 97: 11062-11067, 2000.
40. Michel S, Clark JP, Ding JM, Colwell CS. Brain-derived neurotrophic factor and neurotrophin receptors modulate glutamate-induced phase shifts of the suprachiasmatic nucleus. Eur J Neurosci 24: 1109-1116, 2006a.
41. Michel S, Itri J, Han JH, Gniotczynski K, Colwell CS. Regulation of glutamatergic signalling by PACAP in the mammalian suprachiasmatic nucleus. BMC Neurosci 7: 15, 2006b.
42. Mikkelsen JD, Larsen PJ, Ebling FJ. Distribution of N-methyl d-aspartate (NMDA) receptor mRNAs in the rat suprachiasmatic nucleus. Brain Res 632: 329-333, 1993.
43. Minami Y, Furuno K, Akiyama M, Moriya T, Shibata S. Pituitary adenylate cyclase-activating polypeptide produces a phase shift associated with induction of mPer expression in the mouse suprachiasmatic nucleus. Neuroscience 113: 37-45, 2002.
44. Mintz EM, Albers HE. Microinjection of NMDA into the SCN region mimics the phase shifting effect of light in hamsters. Brain Res 758: 245-249, 1997.
45. Mintz EM, Marvel CL, Gillespie CF, Price KM, Albers HE. Activation of NMDA receptors in the suprachiasmatic nucleus produces light-like phase shifts of the circadian clock in vivo. J Neurosci 19: 5124-5130, 1999.
46. Moriya T, Horikawa K, Akiyama M, Shibata S. Correlative association between N-methyl-D-aspartate receptor-mediated expression of period genes in the suprachiasmatic nucleus and phase shifts in behavior with photic entrainment of clock in hamsters. Mol Pharmacol 58: 1554-1562, 2000a.
47. Moriya T, Takahashi S, Ikeda M, Suzuki-Yamashita K, Asai M, Kadotani H, Okamura H, Yoshioka T, Shibata S. N-methyl-D-aspartate receptor subtype 2C is not involved in circadian oscillation or photoic entrainment of the biological clock in mice. J Neurosci Res 61: 663-673, 2000b.
48. Mott DD, Doherty JJ, Zhang S, Washburn MS, Fendley MJ, Lyuboslavsky P, Traynelis SF, Dingledine R. Phenylethanolamines inhibit NMDA receptors by enhancing proton inhibition. Nat Neurosci 1: 659-667, 1998. (Pubitemid 128406376)
49. Nahm SS, Farnell YZ, Griffith W, Earnest DJ. Circadian regulation and function of voltage-dependent calcium channels in the suprachiasmatic nucleus. J Neurosci 25: 9304-9308, 2005.
50. Nowak L, Bregestovski P, Ascher P, Herbet A, Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurons. Nature 307: 462-465, 1984. (Pubitemid 14132062)
51. C, and NMDA receptor subunit expression in the suprachiasmatic nucleus and other brain regions. Brain Res Mol Brain Res 28: 239-250, 1995.
52. Paoletti P, Ascher P, Neyton J. High-affinity zinc inhibition of NMDA NR1-NR2A receptors. J Neurosci 17: 5711-5725, 1997. (Pubitemid 27310487)
53. Paoletti P, Perin-Dureau F, Fayyazuddin A, Le Goff A, Callebaut I, Neyton J. Molecular organization of a zinc binding n-terminal modulatory domain in a NMDA receptor subunit. Neuron 28: 911-925, 2000.
54. Paul KN, Fukuhara C, Tosini G, Albers HE. Transduction of light in the suprachiasmatic nucleus: evidence for two different neurochemical cascades regulating the levels of Per1 mRNA and pineal melatonin. Neuroscience 119: 137-144, 2003.
55. Pennartz CM, Hamstra R, Geurtsen AM. Enhanced NMDA receptor activity in retinal inputs to the rat suprachiasmatic nucleus during the subjective night. J Physiol 532: 181-194, 2001.
56. Perez-Otano I, Schulteis CT, Contractor A, Lipton SA, Trimmer JS, Sucher NJ, Heinemann SF. Assembly with the NR1 subunit is required for surface expression of NR3A-containing NMDA receptors. J Neurosci 21: 1228-1237, 2001. (Pubitemid 32128767)
57. Perin-Dureau F, Rachline J, Neyton J, Paoletti P. Mapping the binding site of the neuroprotectant ifenprodil on NMDA receptors. J Neurosci 22: 5955-5965, 2002. (Pubitemid 35387640)
58. Petralia RS, Wang YX, Wenthold RJ. The NMDA receptor subunits NR2A and NR2B show histological and ultrastructural localization patterns similar to those of NR1. J Neurosci 14: 6102-6120, 1994.
59. Priestley T, Laughton P, Myers J, Le Bourdelles B, Kerby J, Whiting PJ. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells. Mol Pharmacol 48: 841-848, 1995.
60. Prosser RA, Edgar DM, Heller HC, Miller JD. A possible glial role in the mammalian circadian clock. Brain Res 643: 296-301, 1994.
61. Qian A, Johnson JW. Permeant ion effects on external Mg2+ block of NR1/2D NMDA receptors. J Neurosci 26: 10899-10910, 2006.
62. Rachline J, Perin-Dureau F, Le Goff A, Neyton J, Paoletti P. The micromolar zinc-binding domain on the NMDA receptor subunit NR2B. J Neurosci 25: 308-317, 2005.
63. Ren H, Honse Y, Karp BJ, Lipsky RH, Peoples RW. A site in the fourth membrane-associated domain of the N-methyl-D-aspartate receptor regulates desensitization and ion channel gating. J Biol Chem 278: 276-283, 2003. (Pubitemid 36043573)
64. Sasaki YF, Rothe T, Premkumar LS, Das S, Cui J, Talantova MV, Wong HK, Gong X, Chan SF, Zhang D, Nakanishi N, Sucher NJ, Lipton SA. Characterization and comparison of the NR3A subunit of the NMDA receptor in recombinant systems and primary cortical neurons. J Neurophysiol 87: 2052-2063, 2002. (Pubitemid 34670767)
65. Schurov IL, McNulty S, Best JD, Sloper PJ, Hastings MH. Glutamatergic induction of CREB phosphorylation and Fos expression in primary cultures of the suprachiasmatic hypothalamus in vitro is mediated by coordinate activity of NMDA and non-NMDA receptors. J Neuroendocrinol 11: 43-51, 1999.
66. Shibata S, Watanabe A, Hamada T, Ono M, Watanabe S. N-methyl-Daspartate induces phase shifts in circadian rhythm of neuronal activity of rat SCN in vitro. Am J Physiol Regulatory Integrative Comp Physiol 267: R360-364, 1994.
67. Sica AL, Gootman PM, Ruggiero DA. CO(2)-induced expression of c-fos in the nucleus of the solitary tract and the area postrema of developing swine. Brain Res 837: 106-116, 1999.
68. Silver R, Romero MT, Besmer HR, Leak R, Nunez JM, LeSauter J. Calbindin-D28K cells in the hamster SCN express light-induced Fos. Neuroreport 7: 1224-1228, 1996.
69. Smothers CT, Woodward JJ. Pharmacological characterization of glycine-activated currents in HEK 293 cells expressing N-methyl-D-aspartate NR1 and NR3 subunits. J Pharmacol Exp Ther 322: 739-748, 2007.
70. Sucher NJ, Akbarian S, Chi CL, Leclerc CL, Awobuluyi M, Deitcher DL, Wu MK, Yuan JP, Jones EG, Lipton SA. Developmental and regional expression pattern of a novel NMDA receptor-like subunit (NMDAR-L) in the rodent brain. J Neurosci 15: 6509-6520, 1995.
71. Takayama K, Suzuki T, Miura M. The comparison of effects of various anesthetics on expression of Fos protein in the rat brain. Neurosci Lett 176: 59-62, 1994. (Pubitemid 24231470)
72. Tong G, Takahashi H, Tu S, Shin Y, Talantova M, Zago W, Xia P, Nie Z, Goetz T, Zhang D, Lipton SA, Nakanishi N. Modulation of NMDA receptor properties and synaptic transmission by the NR3A subunit in mouse hippocampal and cerebrocortical neurons. J Neurophysiol 99: 122-132, 2008.
73. Wang LM, Schroeder A, Loh D, Smith D, Lin K, Han JH, Michel S, Hummer DL, Ehlen JC, Albers HE, Colwell CS. Role for the NR2B subunit of the N-methyl-D-aspartate receptor in mediating light input to the circadian system. Eur J Neurosci 27: 1771-1779, 2008.
74. Watanabe M, Inoue Y, Sakimura K, Mishina M. Distinct distributions of five N-methyl-D-aspartate receptor channel subunit mRNAs in the forebrain. J Comp Neurol 338: 377-390, 1993. (Pubitemid 23350986)
75. Whittemore ER, Ilyin VI, Woodward RM. Antagonism of N-methyl-D-aspartate receptors by sigma site ligands: potency, subtype-selectivity and mechanisms of inhibition. J Pharmacol Exp Ther 282: 326-338, 1997.
76. Williams K. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol Pharmacol 44: 851-859, 1993. (Pubitemid 23317299)
77. Williams K. Pharmacological properties of recombinant N-methyl-D-aspartate (NMDA) receptors containing the epsilon 4 (NR2D) subunit. Neurosci Lett 184: 181-184, 1995.
78. Williams K. Separating dual effects of zinc at recombinant N-methyl-D-aspartate receptors. Neurosci Lett 215: 9-12, 1996.
79. Woodhull AM. Ionic blockage of sodium channels in nerve. J Gen Physiol 61: 687-708, 1973.
80. Zheng F, Erreger K, Low CM, Banke T, Lee CJ, Conn PJ, Traynelis SF. Allosteric interaction between the amino terminal domain and the ligand binding domain of NR2A. Nat Neurosci 4: 894-901, 2001.